Uniprogen Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in Kandivali East, Maharashtra, India, established in 2025.
2025 Kandivali East, Maharashtra, India Active
Last Updated:
Access Report
About Uniprogen Pharmaceuticals Private Limited

Uniprogen Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2025 in Kandivali East, Maharashtra, India. it holds CIN: U46497MH2025PTC440353. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Anandkumar Bhanupratap Singh (Managing Director), Sarojlata Singh (Director). It is based at A-8 Rain Basera Rd No 3, Samta Nagar Singh Estate, Kandivali East, Maharashtra, 400101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497MH2025PTC440353

  • Registration Number

    440353

  • Incorporation Date

    18 February 2025

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year
Company report

Uniprogen Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uniprogen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Uniprogen Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anandkumar Bhanupratap Singh Managing Director 18 Feb 2025 Current
Sarojlata Singh Director 18 Feb 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uniprogen Pharmaceuticals.
Uniprogen Pharmaceuticals revenue growth over time
Uniprogen Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uniprogen Pharmaceuticals?

Unlock access to Uniprogen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Uniprogen Pharmaceuticals?

Unlock and access historical data on people associated with Uniprogen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uniprogen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniprogen Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uniprogen Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Anandkumar Bhanupratap Singh was appointed as a Managing Director was appointed as a Managing Director on 18 Feb 2025 & has been associated with this company since 1 year . was completed.

  • Director Appointment

    Sarojlata Singh was appointed as a Director was appointed as a Director on 18 Feb 2025 & has been associated with this company since 1 year . was recorded as a recent event.

  • Company Incorporation

    Uniprogen Pharmaceuticals Private Limited was registered on 18 Feb 2025 with Roc Mumbai & aged 1 year as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uniprogen Pharmaceuticals Private Limited?

The CIN of Uniprogen Pharmaceuticals Private Limited is U46497MH2025PTC440353.

Where is Uniprogen Pharmaceuticals Private Limited headquartered?

Uniprogen Pharmaceuticals Private Limited is headquartered at A-8 Rain Basera Rd No 3, Samta Nagar Singh Estate, Kandivali East, Maharashtra, 400101.

When was Uniprogen Pharmaceuticals Private Limited incorporated?

Uniprogen Pharmaceuticals Private Limited was incorporated on 18 February 2025.

Who are the current directors of Uniprogen Pharmaceuticals Private Limited?

The current directors of Uniprogen Pharmaceuticals Private Limited are

Is Uniprogen Pharmaceuticals Private Limited a listed company?

Uniprogen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Uniprogen Pharmaceuticals Private Limited?

The authorized capital of Uniprogen Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available